safinamide 50 MG Oral Tablet [Xadago]

RxCUI: 1922472
RxNorm name: safinamide 50 MG Oral Tablet [Xadago]
Display name: safinamide 50 MG Oral Tablet [Xadago]
Full name: safinamide 50 MG Oral Tablet [Xadago]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Xadago	SAFINAMIDE MESYLATE	MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.	c4d65f28-983f-42b4-bb23-023ae0fe81b2	2025-10-22	Warnings, Adverse reactions	Exact identifier rxcui: 1922472

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
c4d65f28-983f-42b4-bb23-023ae0fe81b2	safinamide 50 MG Oral Tablet [Xadago]	SBD	20	These highlights do not include all the information needed to use XADAGO ® safely and effectively. See full prescribing information for XADAGO ® . XADAGO ® (safinamide) tablets, for oral use Initial U.S. Approval: 2017	20251022
c4d65f28-983f-42b4-bb23-023ae0fe81b2	Xadago 50 MG Oral Tablet	PSN	20	These highlights do not include all the information needed to use XADAGO ® safely and effectively. See full prescribing information for XADAGO ® . XADAGO ® (safinamide) tablets, for oral use Initial U.S. Approval: 2017	20251022
c4d65f28-983f-42b4-bb23-023ae0fe81b2	Xadago 50 MG (as safinamide mesylate 65.88 MG) Oral Tablet	SY	20	These highlights do not include all the information needed to use XADAGO ® safely and effectively. See full prescribing information for XADAGO ® . XADAGO ® (safinamide) tablets, for oral use Initial U.S. Approval: 2017	20251022
c4d65f28-983f-42b4-bb23-023ae0fe81b2	Xadago 50 MG Oral Tablet	SY	20	These highlights do not include all the information needed to use XADAGO ® safely and effectively. See full prescribing information for XADAGO ® . XADAGO ® (safinamide) tablets, for oral use Initial U.S. Approval: 2017	20251022